EYEG Market Cap History
Below is a table of the EYEG market cap history going back to 3/27/2015:

Date EYEG Market Cap
3/27/201519.95M
5/14/201532.97M
5/15/201532.97M
7/29/2015100.38M
8/12/201534.59M
11/6/201525.26M
3/28/201625.46M
5/13/201626.21M
8/10/201618.44M
11/1/201614.24M
2/17/201716.79M
5/3/201721.04M
8/2/201720.65M
11/10/201719.27M
2/28/20189.84M
5/9/201820.61M
8/1/201822.98M
11/9/201813.90M
2/27/201919.05M
5/6/201911.62M
8/6/20199.55M
8/30/20197.73M
11/5/201915.09M
3/2/202026.28M
3/31/202024.06M
8/4/202019.06M

Also see: EYEG Shares Outstanding History
and EYEG YTD Return
EYEG Historical Market Cap:
-0.85% CAGR
EYEG Historical Market Cap: +-0.85% CAGR

Mouse over chart for data details
3/27/2015 ...8/4/2020
Eyegate Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing products for treating disorders of the eye. Co.'s key product in clinical development is the EyeGate Ocular Bandage Gel, a topically applied eye drop formulation of modified hyaluronic acid (HA). HA is a naturally occurring polymer that is used in various physiological processes, including wound healing, hydration, tissue homeostasis, and joint lubrication. Co. modifies the HA through chemical cross-linking, which allows it to adhere to the ocular surface providing protection and lubrication for the treatment of corneal wounds, defects, and epitheliopathies. We show 26 historical shares outstanding datapoints in our EYEG shares outstanding history coverage, used to compute EYEG market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing EYEG market cap history over the course of time is important for investors interested in comparing EYEG's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of EYEG versus a peer is one thing; comparing EYEG market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like EYEG can fluctuate over the course of history. With this page we aim to empower investors researching EYEG by allowing them to research the EYEG market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for EYEG:
EYEG SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Eyegate Pharmaceuticals (EYEG) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

EYES Market Cap History
FATE Market Cap History
FCRE Market Cap History
FCSC Market Cap History
FGEN Market Cap History
FLDM Market Cap History
FLGT Market Cap History
FLKS Market Cap History
FLXN Market Cap History
FMI Market Cap History
More Healthcare companies »

 

EYEG Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.